首页 > 资讯 > 数字健康公司Ro推出GLP

数字健康公司Ro推出GLP

泰然健康网
2025-07-16 08:48

Zoom In IconArrows pointing outwardsRoThe direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s. Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly $1,000 monthly price tag of the medications.

放大Iconrowns指向外部的Roth direct to consumer health care startup Ro周二推出了一个新的免费工具，帮助患者确定他们的保险是否涵盖了一类热门的减肥和糖尿病药物GLP-1s。当GLP-1用于治疗糖尿病时，大多数保险计划都涵盖了GLP-1，因此这些患者通常可以避免每月大约1000美元的药物价格。

But coverage of weight loss treatments is less widespread, and navigating the complex insurance landscape can be challenging for patients and time consuming for doctors who prescribe the medications. Some patients may be missing out on treatment because they simply don't know they have coverage. Ro said nearly half of the company's patients have some form of insurance coverage for a GLP-1, according to its customer data. Ro said it hopes its new tool can help patients understand their coverage options so they can decide how to pursue weight loss.

但减肥治疗的覆盖面不太广，复杂的保险环境对患者来说是一个挑战，对开处方的医生来说也是一个耗时的过程。一些患者可能会错过治疗，因为他们根本不知道自己有覆盖范围。罗表示，根据其客户数据，该公司近一半的患者都有某种形式的GLP-1保险。Ro表示，它希望它的新工具能够帮助患者了解他们的覆盖范围选择，以便他们可以决定如何减肥。

The digital health company may benefit too, as it could drive some patients to join the company's GLP-1 program.Demand for GLP-1s, including Novo Nordisk's weight loss treatment Wegovy and diabetes injection Ozempic, has outstripped supply over the last year in the U.S. Other drugmakers — and digital health companies like Ro — are scrambling to capitalize on the booming GLP-1 market, which analysts say could be worth more than $100 billion by the end of the decade. Patients in Ro's program can get prescribed a GLP-1, and the company also offers compounded versions of the medication when the branded versions are in short supply.

数字健康公司也可能受益，因为它可能会促使一些患者加入该公司的GLP-1计划。去年，包括诺和诺德公司（Novo Nordisk）的减肥治疗药物Wegovy和糖尿病注射液Ozempic在内的GLP-1的需求超过了美国的供应。其他制药商——以及像Ro这样的数字健康公司——正争先恐后地利用蓬勃发展的GLP-1市场，分析师表示，到本十年末，该市场的价值可能超过1000亿美元。Ro计划中的患者可以获得GLP-1处方，当品牌药物短缺时，该公司还提供复合药物。

Compounded GLP-1s are custom-made alternatives to brand drugs designed to meet a specific patient's needs. The program also allows patients to meet monthly with a doctor and access an educational curriculum f.

复合GLP-1是定制的替代品牌药物，旨在满足特定患者的需求。该计划还允许患者每月与医生会面，并获得教育课程f。